期刊文献+

中西医结合在慢性阻塞性肺疾病患者中的临床效果及对肺功能的影响研究 被引量:1

Clinical effect of combination of traditional Chinese medicine and western medicine in patients with chronic obstructive pulmonary disease and its effect on pulmonary function
下载PDF
导出
摘要 目的分析中西医结合治疗慢性阻塞性肺疾病(Chronic obstructive pulmonary disease,COPD)的临床治疗效果。方法选取2014年12月~2016年12月在本院接受治疗的COPD患者160例,随机分为2组,对照组仅给予西药治疗,观察组进行中西医结合治疗。对比2组治疗效果。结果观察组治疗有效率为88.75%,对照组治疗有效率为76.25%(P〈0.05)。治疗后,观察组FEV1为(1.85±0.42)L,FVC为(1.64±0.33)L。对照组FEV1为(2.56±0.35)L,FVC为(2.32±0.37)L,观察组改善更加明显(P〈0.05)。观察组不良反应发生率为8.75%,对照组为7.50%,差异无统计学意义。结论中西医结合治疗COPD的临床效果显著,值得推广。 Objective To analyze the clinical treatment effect of traditional Chinese medicine and western medicine in the treatment of chronic obstructive pulmonary disease. Methods 160 patients with COPD from December 2014 to December 2016 in our hospital were enrolled in this study. and randomly divided into two groups. The control group was treated with western medicine only. The observation group was treated with traditional Chinese medicine and western medicine. The therapeutic effects of the two groups were compared. Results The effective rate was 88. 75% in the observation group and 76. 25% in the control group( P 〈0. 05). After treatment,FEV1was( 1. 85 ± 0. 42) L and FVC was( 1. 64 ± 0. 33) L in the observation group. In the control group,FEV1was( 2. 56 ± 0. 35) L,FVC was( 2. 32 ± 0. 37) L,the improvement of the observation group was more obvious( P 〈0. 05). The incidence of adverse reactions was 8. 75% in the observation group and 7. 50% in the control group,the difference was not statistically significant. Conclusion The clinical effect of traditional Chinese and western medicine in the treatment of COPD is remarkable and worthy of promotion.
作者 陈建毅
出处 《中国生化药物杂志》 CAS 2017年第7期134-135,共2页 Chinese Journal of Biochemical Pharmaceutics
关键词 中西医结合 慢性阻塞性肺疾病 肺功能 细胞因子 integrative medicine chronic obstructive pulmonary disease lung function cytokines
  • 相关文献

参考文献4

二级参考文献116

  • 1肖建,杜春玲.慢性阻塞性肺疾病病因及发病机制研究进展[J].中国老年学杂志,2014,34(11):3191-3194. 被引量:165
  • 2李现东,韩纪昌,李磊,贾宗岭,李红兵,吴雪雁.肿瘤坏死因子-α和可溶性肿瘤坏死因子受体在慢性阻塞性肺病患者肺功能变化中的表达及意义[J].中国老年学杂志,2014,34(2):357-358. 被引量:19
  • 3刘涌,赵蜀军,蔡圣荣,方志斌,王元勋.慢性支气管炎肺气虚证大鼠丙二醛、肿瘤坏死因子-α的改变及意义[J].中医药临床杂志,2007,19(1):26-27. 被引量:8
  • 4Ross Vlahos, Steven Bozinovski. Recent advances in pre- clinical mouse models of COPD [ J]. Clin Sci,2014,126 (4) :253-265.
  • 5Gosselink J V, Hayashi S, Elliott W M, et al. Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease [ J ]. Am J Respir Crit Care Med ,2010,181 ( 12 ) : 1329- 1335.
  • 6Hogg J C, McDonough J E, Gosselink J V, et al. What drives the peripheral lung-remodeling process in chronic obstructive pulmonary disease[ J]. Proc Am Thorac Soc, 2009, 6(8) :668-672.
  • 7Harju T, Kinnula V L, Paakko P, et al. Variability in the precursor proteins of collagen I and HI in different stages of COPD [ J ]. Respir Res, 2010,11 ( 1 ) : 165-167.
  • 8Qaseem A, Wih T J,Weinberger S E, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American college of physicians, American college of chest physicians, American thoracic society and european respiratory society [ J ]. Ann Intern Med,2011,155 ( 3 ) : 179-191.
  • 9Kim V, Rogers T J, Criner G J. New concepts in the pathobiology of chronic obstructive pulmonary disease [J]. Proc Am Thorac Soc,2008,5(4) :478-485.
  • 10Vestbo J, Hurd SS, Agusti AG, et al. Global initiative for chronic obstructive lung disease., global strategy for the diagnosis, management, and prevention of chronic ob- structive pulmonary disease[J]. Am J Respir Crit Care Med, 2013,187(4) :347-365.

共引文献152

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部